HIGHLIGHTS
- who: Top from the Department of Medicine, Pennsylvania State University College of Medicine and Penn State Hershey Cancer Institute, Hershey, PA, USA have published the research: mantle cell lymphoma, in the Journal: (JOURNAL)
- what: The authors report an increased OS greater than 40 months with several patients maintaining durable remissions without relapse for longer than 5 years. The authors demonstrate that the G/A870 CCND1 polymorphism is predictive of blastic disease nuclear localization of cyclinD1 and response to SCR therapy. The authors report the characteristics, results and data to support antibody dependent cellular cytotoxicity (ADCC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.